Stay updated on ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new revision entry (v3.7.0) was added to the record history, replacing the previous v3.6.6. This reflects an update to the study record's metadata.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe record history adds a new revision entry (v3.6.6) and removes the previous revision (v3.6.5) from the visible history, updating the page's version trail.SummaryDifference0.1%

- Check51 days agoChange DetectedA new release entry Revision: v3.6.5 was added to the record history, and the previous entry Revision: v3.6.4 was removed, reflecting an update to the page's versioning in the study record history.SummaryDifference0.1%

- Check65 days agoChange DetectedThe study record history now lists a new revision, v3.6.4, indicating the page has been updated. This reflects a version-control entry rather than a substantive content change.SummaryDifference0.1%

- Check87 days agoChange DetectedThe record history now shows a new release entry for Revision v3.6.3, replacing the previous v3.6.2, indicating an update to the record's metadata.SummaryDifference0.1%

- Check94 days agoChange DetectedA new release entry 'Revision: v3.6.2' is added to the study record history, indicating a site update. The older 'Revision: v3.6.0' entry is removed, reflecting the supersession of a previous revision.SummaryDifference0.1%

Stay in the know with updates to ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.